Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 20, 2016
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), announced that it entered into a new agreement for the cGMP manufacturing of UCART123 clinical batches, Cellectis’ lead product ...
read more
Friday, February 15, 2019
The FDA has issued a final rule under section 503A of the FDCA, placing six bulk drug substances on the list of substances that compounders can use to compound drugs, known as the 503A bulks list.
read more
Ubiquigent announced the continuation of a collaboration with Bristol Myers Squibb.
read more
Monday, December 28, 2015
ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, has entered into a Product Development & Contract Manufacture ...
read more
Wednesday, January 31, 2018
A group of industry investors has announced the acquisition of CorePharma, its facilities and equipment in Middlesex, NJ from Impax Laboratories.
read more
Agilent Technologies announced that it is breaking ground on a 15,000-square-foot expansion of the company’s logistics center in Cedar Creek, Texas.
read more
Thursday, December 27, 2018
Helsinn and Menarini announced that Berlin Chemie AG, the German company of the Menarini Group, has been granted exclusive licensing rights to commercialize Pracinostat worldwide.
read more
Avid Bioservices has signed two new contract manufacturing service agreements to support the development of novel drug candidates.
read more
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) has created the Pharmatek Foundation, a not-for-profit organization supporting volunteerism for causes in the San Diego community. The Foundation's ...
read more
Peregrine Pharmaceuticals has reduced its overall workforce by 60 employees.
read more
SSI Strategy announced that it has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy.
read more
Perceptive Discovery announced a major expansion of its in vitro laboratory capabilities at its Needham, Massachusetts facility. This strategic investment significantly enhances the company's ability to support preclinical oncology research, ...
read more
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, ...
read more
Wednesday, September 09, 2020
APIS Assay Technologies has announced the acquisition of Beogenomics, a specialized software developer with proficiency in Bioinformatics and Artificial Intelligence (BIOX).
read more
Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals. Through the agreement Evonik will produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in Tippecanoe, Indiana, USA and Dossenheim, Germany.
read more